Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 45, 2016 - Issue 5
216
Views
3
CrossRef citations to date
0
Altmetric
Review

Anti-Inflammatory Effects of Modified Adenoviral Vectors for Gene Therapy: A View through Animal Models Tested

, , , &

References

  • Adriaansen J, Vervoordeldonk MJ, Tak, PP. (2006). Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes. Rheumatology (Oxford), 45(6), 656–68. doi: 10.1093/rheumatology/kel047.
  • Andrews JL, Kadan MJ, Gorziglia MI, et al. (2001). Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.” Mol Ther, 3(3), 329–36. doi: 10.1006/mthe.2001.0264.
  • Arnaiz-Villena A, Regueiro JR, López Larrea C. (1995). Inmunología. 1 ed. Vol. 1. Madrid: Editorial Complutense.
  • Arntz OJ, Geurts J, Veenbergen S, et al. (2010). A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis. Arthritis Res Ther, 12(2), R61. doi: 10.1186/ar2974.
  • Astrakhantseva IV, Efimov GA, Drutskaya MS, et al. (2014). Modern anti-cytokine therapy of autoimmune diseases. Biochemistry (Mosc), 79(12), 1308–21. doi: 10.1134/S0006297914120049.
  • Baldwin AG, Brough D, Freeman S. (2015). Inhibiting the inflammasome: A chemical perspective. J Med Chem, doi: 10.1021/acs.jmedchem.5b01091.
  • Baragi VM, Renkiewicz RR, Jordan H, et al. 1995. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J Clin Invest, 96(5), 2454–60. doi: 10.1172/JCI118303.
  • Bennett GJ, Xie YK. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 33(1), 87–107.
  • Beyaert R, Beaugerie L, Van Assche G, et al. (2013). Cancer risk in immune-mediated inflammatory diseases (IMID). Mol Cancer, 12(1), 98. doi: 10.1186/1476-4598-12-98.
  • Bondeson J, Browne KA, Brennan FM, et al. (1999). Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independent. J Immunol, 162(5), 2939–45.
  • Brydges SD, Mueller JL, McGeough MD, et al. (2009). Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity, 30(6), 875–87. doi: 10.1016/j.immuni.2009.05.005.
  • Burgert HG, Ruzsics Z, Obermeier S, et al. (2002). Subversion of host defense mechanisms by adenoviruses. Curr Top Microbiol Immunol, 269, 273–318.
  • Campos SK, Barry MA. (2007). Current advances and future challenges in adenoviral vector biology and targeting. Curr Gene Ther, 7(3), 189–204.
  • Catley MC, Chivers JE, Holden NS, et al. (2005). Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells. Br J Pharmacol, 145(1), 114–22. doi: 10.1038/sj.bjp.0706170.
  • Chaudhry A, Rudensky AY. 2013. Control of inflammation by integration of environmental cues by regulatory T cells. J Clin Invest, 123(3), 939–44. doi: 10.1172/JCI57175.
  • Chou AK, Yang MC, Tsai HP, et al. (2014). Adenoviral-mediated glial cell line-derived neurotrophic factor gene transfer has a protective effect on sciatic nerve following constriction-induced spinal cord injury. PLoS One, 9(3), e92264. doi: 10.1371/journal.pone.0092264.
  • Ciccarelli F, De Martinis M, Ginaldi L. (2014). An update on autoinflammatory diseases. Curr Med Chem, 21(3), 261–9.
  • Connelly S. (1999). Adenoviral vectors for liver-directed gene therapy. Curr Opin Mol Ther, 1(5), 565–72.
  • Cossu F. (2010). Genetics of SCID. Ital J Pediatr, 36, 76. doi: 10.1186/1824-7288-36-76.
  • Crystal RG. (2014). Adenovirus: the first effective in vivo gene delivery vector. Hum Gene Ther, 25(1), 3–11. doi: 10.1089/hum.2013.2527.
  • Dai P, Cao H, Merghoub T, Avogadri F, et al. (2011). Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway. J Virol, 85(20), 10814–25. doi: 10.1128/JVI.00104-11.
  • Dass S, Vital EM, Emery P. (2006). Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis. Expert Opin Pharmacother, 7(18), 2559–70. doi: 10.1517/14656566.7.18.2559.
  • Davidson A, Diamond B. (2001). Autoimmune diseases. N Engl J Med, 345(5), 340–50. doi: 10.1056/NEJM200108023450506.
  • Davison AJ, Benko M, Harrach B. (2003). Genetic content and evolution of adenoviruses. J Gen Virol, 84(Pt 11), 2895–908. doi: 10.1099/vir.0.19497-0.
  • DeMatteo RP, Raper SE, Ahn M, et al. (1995). Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirus. Ann Surg, 222 (3), 229–39; discussion 39-42.
  • Dhabhar FS, McEwen BS, Spencer RL. (1993). Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels–a comparison between Sprague-Dawley, Fischer 344 and Lewis rats. Brain Res, 616(1–2), 89–98.
  • Ebina K, Oshima K, Matsuda M, et al. (2009). Adenovirus-mediated gene transfer of adiponectin reduces the severity of collagen-induced arthritis in mice. Biochem Biophys Res Commun, 378(2), 186–91. doi: 10.1016/j.bbrc.2008.11.005.
  • El-Gabalawy H, Guenther LC, Bernstein CN. (2010). Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J Rheumatol Suppl, 85, 2–10. doi: 10.3899/jrheum.091461.
  • Engelhardt JF, Yang Y, Stratford-Perricaudet LD, et al. (1993). Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat Genet, 4(1), 27–34. doi: 10.1038/ng0593-27.
  • Esber HJ, Menninger FF, Jr, Bogden AE. (1974). Variation in serum hormone concentrations in different rat strains. Proc Soc Exp Biol Med, 146(4), 1050–3.
  • Fan G, Fan M, Wang Q, et al. (2016). Bio-inspired polymer envelopes around adenoviral vectors to reduce immunogenicity and improve in vivo kinetics. Acta Biomater, 30, 94–105. doi: 10.1016/j.actbio.2015.11.005.
  • Filardy AA, Costa-da-Silva AC, Koeller CM, et al. (2014). Infection with Leishmania major induces a cellular stress response in macrophages. PLoS One, 9(1), e85715. doi: 10.1371/journal.pone.0085715.
  • Fink D, Romanowski K, Valuckaite V, et al. (2011). Pseudomonas aeruginosa potentiates the lethal effect of intestinal ischemia-reperfusion injury: the role of in vivo virulence activation. J Trauma, 71(6), 1575–82. doi: 10.1097/TA.0b013e31821cb7e5.
  • Fleischmann RM. (2003). Addressing the safety of anakinra in patients with rheumatoid arthritis. Rheumatology (Oxford), 42(Suppl 2), ii29–35. doi: 10.1093/rheumatology/keg330.
  • Garza-Veloz I, Romero-Diaz VJ, Martinez-Fierro ML, et al. (2013). Analyses of chondrogenic induction of adipose mesenchymal stem cells by combined co-stimulation mediated by adenoviral gene transfer. Arthritis Res Ther, 15(4), R80. doi: 10.1186/ar4260.
  • Gilgenkrantz H, Duboc D, Juillard V, et al. (1995). Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum Gene Ther, 6(10), 1265–74. doi: 10.1089/hum.1995.6.10-1265.
  • Goettel JA, Biswas S, Lexmond WS, et al. (2015). Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3. Blood, 125(25), 3886–95. doi: 10.1182/blood-2014-12-618363.
  • Gudjonsson JE, Elder JT. (2007). Psoriasis: epidemiology. Clin Dermatol, 25(6), 535–46. doi: 10.1016/j.clindermatol.2007.08.007.
  • Hashkes PJ, Spalding SJ, Hajj-Ali R, et al. (2014). The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean fever. Biomed Res Int, 2014, 854842. doi: 10.1155/2014/854842.
  • Hashkes PJ, Toker O. (2012). Autoinflammatory syndromes. Pediatr Clin North Am, 59(2), 447–70. doi: 10.1016/j.pcl.2012.03.005.
  • Herenu CB, Sonntag WE, Morel GR, et al. (2009). The ependymal route for insulin-like growth factor-1 gene therapy in the brain. Neuroscience, 163(1), 442–7. doi: 10.1016/j.neuroscience.2009.06.024.
  • Hogaboam CM, Vallance BA, Kumar A, et al. (1997). Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J Clin Invest, 100(11), 2766–76. doi: 10.1172/JCI119823.
  • Kacew S, Festing MF. (1996). Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances. J Toxicol Environ Health, 47(1), 1–30. doi: 10.1080/009841096161960-2840.
  • Kim SH, Kim S, Evans CH, et al. (2001). Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol, 166(5), 3499–505.
  • Kirk RG (2012) “Life in a germ-free world”: isolating life from the laboratory animal to the bubble boy. Bull Hist Med, 86(2), 237–75. doi: 10.1353/bhm.2012.0028.
  • Krasnykh V, Dmitriev I, Mikheeva G, et al. (1998). Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol, 72(3), 1844–52.
  • Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. (1996). Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol, 70(10), 6839–46.
  • Kreppel F, Kochanek S. (2008). Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide. Mol Ther, 16(1), 16–29. doi: 10.1038/sj.mt.6300321.
  • Kuek A, Hazleman BL, Ostor AJ. (2007). Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J, 83(978), 251–60. doi: 10.1136/pgmj.2006.052688.
  • Lefevre S, Knedla A, Tennie C, et al. (2009). Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med, 15(12), 1414–20. doi: 10.1038/nm.2050.
  • Li T, Adamian M, Roof DJ, Berson EL, et al. (1994). In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest Ophthalmol Vis Sci, 35(5), 2543–9.
  • Liu W, Feng W, Wang F, et al. (2008). Adenovirus-mediated ICOSIg gene transfer alleviates cardiac remodeling in experimental autoimmune myocarditis. Immunol Cell Biol, 86(8), 659–65. doi: 10.1038/icb.2008.45.
  • Liu XF, Shi Y, Zhang JY, et al. (2009). Efficient adenovirus-mediated gene transfer to gastric tissue by oral administration. J Gene Med, 11(12), 1087–94. doi: 10.1002/jgm.1397.
  • Lodde BM, Mineshiba F, Wang J. (2006). Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren’s syndrome. Ann Rheum Dis 65(2), 195–200. doi: 10.1136/ard.2005.038232.
  • Lopez Hernandez Y, Yero D, Pinos-Rodriguez JM, Gibert I. (2015). Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens. Front Microbiol, 6, 38. doi: 10.3389/fmicb.2015.00038.
  • Lucey DR, Clerici M, Shearer, GM (1996) Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev, 9(4), 532–62.
  • Maeda S, Kawamoto A, Yatani Y, et al. (2008). Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats. Mol Pain, 4, 65. doi: 10.1186/1744-8069-4-65.
  • Maini R, St Clair EW, Breedveld F, et al. (1999). Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet, 354( 9194), 1932–9.
  • Mastrandrea LD. (2015). An overview of organ-specific autoimmune diseases including immunotherapy. Immunol Invest, 44(8), 803–16. doi: 10.3109/08820139.2015.1099409.
  • McCray PB, Jr, Armstrong K, Zabner J, et al. (1995). Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest, 95(6), 2620–32. doi: 10.1172/JCI117964.
  • McDermott MF, Aksentijevich I, Galon J, et al. (1999). Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell, 97(1), 133–44.
  • McGonagle D, McDermott MF. (2006). A proposed classification of the immunological diseases. PLoS Med, 3(8), e297. doi: 10.1371/journal.pmed.0030297.
  • McIndoe RA, Bohlman B, Chi E, et al. (1999). Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc Natl Acad Sci U S A, 96(5), 2210–4.
  • Mi Z, Ghivizzani SC, Lechman E, et al. (2003). Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Res Ther, 5(3), R132–9.
  • Nabbe KC, van Lent PL, Holthuysen AE, et al. (2005). Local IL-13 gene transfer prior to immune-complex arthritis inhibits chondrocyte death and matrix-metalloproteinase-mediated cartilage matrix degradation despite enhanced joint inflammation. Arthritis Res Ther, 7(2), R392–401. doi: 10.1186/ar1502.
  • Oitzl MS, van Haarst AD, Sutanto W, de Kloet ER. (1995). Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology, 20(6), 655–75.
  • Ostrov BE. (2015). Immunotherapeutic biologic agents in autoimmune and autoinflammatory diseases. Immunol Invest, 44(8), 777–802. doi: 10.3109/08820139.2015.1093912.
  • Penberthy KK, Ravichandran KS. (2016). Apoptotic cell recognition receptors and scavenger receptors. Immunol Rev, 269(1), 44–59. doi: 10.1111/imr.12376.
  • Peng X, Knouse JA, Hernon KM. (2015). Rabbit models for studying human infectious siseases. Comp Med, 65(6), 499–507.
  • Pierer M, Muller-Ladner U, Pap T, et al. (2003). The SCID mouse model: novel therapeutic targets - lessons from gene transfer. Springer Semin Immunopathol, 25(1), 65–78. doi: 10.1007/s00281-003-0126-2.
  • Quattrocchi E, Dallman MJ, Dhillon AP, et al. (2001). Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J Immunol, 166(10), 5970–8.
  • Rosenfeld MA, Siegfried W, Yoshimura K, et al. (1991). Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science, 252(5004), 431–4.
  • Russo RA, Brogan PA. (2014). Monogenic autoinflammatory diseases. Rheumatology (Oxford), 53(11), 1927–39. doi: 10.1093/rheumatology/keu170.
  • Ryu CH, Park KY, Hou Y, et al. (2013). Gene therapy of multiple sclerosis using interferon beta-secreting human bone marrow mesenchymal stem cells. Biomed Res Int, 2013:696738. doi: 10.1155/2013/696738.
  • Sanjuan MA, Rao N, Lai KT, et al. (2006). CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J Cell Biol, 172(7), 1057–68. doi: 10.1083/jcb.200508058.
  • Serhan CN, Chiang N, Van Dyke TE. (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol, 8(5), 349–61. doi: 10.1038/nri2294.
  • Shimizu K. (2015). Development and characterization of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes. Yakugaku Zasshi, 135(12), 1349–56. doi: 10.1248/yakushi.15-00190.
  • Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. (2012). Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol, 12(11), 786–98. doi: 10.1038/nri3311.
  • Shurin MR. (2007). Immune-mediated diseases: from theory to therapy. 10–15 September 2007, Moscow, Russia. IDrugs, 10( 11), 762–4.
  • Silman AJ, Pearson JE. (2002). Epidemiology and genetics of rheumatoid arthritis. Arthritis Res, 4(Suppl 3), S265–72.
  • Sitohy B, Nagy JA, Dvorak HF. (2012). Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res, 72(8), 1909–14. doi: 10.1158/0008-5472.CAN-11-3406.
  • St Louis JM, Pasick JM, Stein C, et al. (1994). Lewis rat T cells can reutilize, process, and present myelin basic protein to antigen-specific T cell lines. Cell Immunol, 156(1), 36–53. doi: 10.1006/cimm.1994.1151.
  • Sumida SM, Truitt DM, Kishko MG, et al. (2004). Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors. J Virol, 78(6), 2666–73.
  • Sun Y, Zhu Y, Wang L, et al. (2013). Recombinant adenovirus-mediated intestinal trefoil factor gene therapy for burn-induced intestinal mucosal injury. PLoS One, 8(4), e62429. doi: 10.1371/journal.pone.0062429.
  • Takahashi M, Tsujimura N, Yoshino T, et al. (2012). Assessment of benzene-induced hematotoxicity using a human-like hematopoietic lineage in NOD/Shi-scid/IL-2Rgammanull mice. PLoS One, 7(12), e50448. doi: 10.1371/journal.pone.0050448.
  • Tang B, Cullins DL, Zhou J, et al. (2010). Modulation of collagen-induced arthritis by adenovirus-mediated intra-articular expression of modified collagen type II. Arthritis Res Ther, 12(4), R136. doi: 10.1186/ar3074.
  • Tosi MF, van Heeckeren A, Ferkol TW, et al. (2004). Effect of Pseudomonas-induced chronic lung inflammation on specific cytotoxic T-cell responses to adenoviral vectors in mice. Gene Ther, 11(19), 1427–33. doi: 10.1038/sj.gt.3302290.
  • van der Goes MC, Jacobs JW, Bijlsma JW. (2014). The value of glucocorticoid co-therapy in different rheumatic diseases–positive and adverse effects. Arthritis Res Ther, 16(Suppl 2), S2. doi: 10.1186/ar4686.
  • Vannucci L, Lai M, Chiuppesi F, et al. (2013). Viral vectors: a look back and ahead on gene transfer technology. New Microbiol, 36(1), 1–22.
  • Volpers C, Kochanek S. (2004). Adenoviral vectors for gene transfer and therapy. J Gene Med, 6(Suppl 1), S164–71. doi: 10.1002/jgm.496.
  • Wilson SP, Cassel SL. (2010). Inflammasome-mediated autoinflammatory disorders. Postgrad Med, 122(5), 125–33. doi: 10.3810/pgm.2010.09.2209.
  • Wold WS, Toth K. (2013). Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther, 13(6), 421–33.
  • Wu F, Xu X, Miao X, et al. (2012). Effect of recombinant adenovirus coding for endomorphin-2 on neuropathic pain in rats. Int J Clin Exp Pathol, 5(9), 914–23.
  • Xie J, Guo X, Liu F, et al. (2015). In vitro antitumor immune response induced by dendritic cells transduced with human livin alpha recombinant adenovirus. Cell Immunol, 297(1), 46–52. doi: 10.1016/j.cellimm.2015.06.003.
  • Yang Y, Li Q, Ertl HC, Wilson JM. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol, 69, 2004–15.
  • Yao Q, Wang S, Gambotto A, et al. (2003). Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium. Gene Ther, 10(12), 1055–60. doi: 10.1038/sj.gt.3301881.
  • Yin H, Li XY, Yuan BH, et al. (2011). Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice. Clin Exp Immunol, 164(2), 248–55. doi: 10.1111/j.1365-2249.2011.04326.x.
  • Ylosmaki E, Hakkarainen T, Hemminki A, et al. (2008). Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA. J Virol, 82(22), 11009–15. doi: 10.1128/JVI.01608-08.
  • Yuan B, Zhao Z, Zhang YR, et al. (2008). Short-term safety and curative effect of recombinant adenovirus carrying hepatocyte growth factor gene on ischemic cardiac disease. In Vivo, 22(5), 629–32.
  • Zhu W, Zhang K, Mix E, et al. (2011). Differential susceptibility to experimental autoimmune neuritis in Lewis rat strains is associated with T-cell immunity to myelin antigens. J Neurosci Res, 89(3), 448–56. doi: 10.1002/jnr.22541.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.